Greenearth Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 3.60 M
as on 20-12-2024
- Company Age 33 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.48 Cr
as on 20-12-2024
- Revenue 872.92%
(FY 2022)
- Profit 65.76%
(FY 2022)
- Ebitda 99.93%
(FY 2022)
- Net Worth -0.06%
(FY 2022)
- Total Assets -0.05%
(FY 2022)
About Greenearth Biotechnologies
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.60 M.
The company has closed loans amounting to ₹2.48 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Udayant Malhoutra, Jagatbir Sandhu, and Suresh Naidu serve as directors at the Company.
- CIN/LLPIN
U85110KA1991PLC012371
- Company No.
012371
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Sep 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Greenearth Biotechnologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Naidu  | Director | 07-Sep-2015 | Current |
| Udayant Malhoutra | Director | 30-Sep-1991 | Current |
| Jagatbir Sandhu | Director | 30-Sep-1991 | Current |
Financial Performance and Corporate Structure Insights of Greenearth Biotechnologies.
Greenearth Biotechnologies Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 872.92% increase. The company also saw a substantial improvement in profitability, with a 65.76% increase in profit. The company's net worth dipped by a decrease of 0.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Greenearth Biotechnologies?
In 2022, Greenearth Biotechnologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
San Engineering And Locomotive Company Limited.Active 51 years 2 monthsUdayant Malhoutra is a mutual person
- Christine Hoden (India) Private LimitedActive 57 years 8 months
Udayant Malhoutra and Suresh Naidu are mutual person
- Primella Sanitary Products Private LimitedActive 50 years 3 months
Udayant Malhoutra and Suresh Naidu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka State Industrial Investment And Development Corpn Ltd Creation Date: 29 May 1998 | ₹1.08 Cr | Satisfied |
Canara Bank Creation Date: 09 Aug 1996 | ₹2.70 M | Satisfied |
Karnataka State Industrial Investment And Development Corpn Ltd Creation Date: 26 Jun 1995 | ₹0.46 M | Satisfied |
How Many Employees Work at Greenearth Biotechnologies?
Unlock and access historical data on people associated with Greenearth Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greenearth Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greenearth Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
